Q3 2020 Holdings
Filed 2020-11-16 | 126 holdings | $673.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $251.6M | 6,706,268 | 37.4% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $66.7M | 3,636,485 | 9.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $57.3M | 3,659,381 | 8.5% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $46.6M | 6,285,458 | 6.9% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $43.1M | 1,143,790 | 6.4% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $42.8M | 2,058,068 | 6.4% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $40.4M | 830,000 | 6.0% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $39.6M | 16,584,802 | 5.9% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $36.6M | 1,047,404 | 5.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $17.1M | 2,577,043 | 2.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $8.6M | 216,449 | 1.3% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $8.5M | 1,750,000 | 1.3% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $3.7M | 561,574 | 0.6% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $3.2M | 400,000 | 0.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $738.0K | 49,751 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $570.5K | 3,435,575 | 0.1% |
| Retrophin Inc | NOTE 2.500% 9/1 | 761299AB2 | $390.1K | $45,000,000 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $354.7K | 25,122,048 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $332.0K | 10,085,632 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $319.9K | 5,800,996 | 0.0% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $252.0K | 489 | 0.0% |
| Cytokinetics Inc | NOTE 4.000%11/1 | 23282WAA8 | $218.3K | $9,770,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $205.0K | 4,400,999 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $190.2K | 1,395,017 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $165.9K | 3,481,148 | 0.0% |
| Collegium Pharmaceutical Inc | NOTE 2.625% 2/1 | 19459JAA2 | $163.8K | $17,500,000 | 0.0% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $161.3K | 13,532,467 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $157.4K | 55,042,465 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $148.9K | 1,548,715 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $142.4K | 2,847,822 | 0.0% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $141.8K | $9,000,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $115.1K | 826,164 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $112.2K | 1,341,308 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $99.2K | 2,329,407 | 0.0% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $85.2K | 6,433,277 | 0.0% |
| Quotient LTD | SHS | G73268107 | $83.3K | 16,200,818 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $78.8K | 2,360,139 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $77.6K | 912,140 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $76.7K | 707,715 | 0.0% |
| Frequency Therapeutics Inc | COM | 35803L108 | $62.6K | 3,256,518 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $62.3K | 1,250,000 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $61.8K | 1,043,021 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $61.6K | 664,574 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $61.6K | 15,711,334 | 0.0% |
| Retrophin Inc | COM | 761299106 | $59.8K | 3,240,112 | 0.0% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $58.6K | 848,500 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $57.5K | 3,114,805 | 0.0% |
| Provention BIO Inc(PRVBUSD) | COM | 74374N102 | $54.7K | 4,265,711 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $50.0K | 2,189,010 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $49.3K | 1,400,000 | 0.0% |